Ticker
PRPHCompany Name
PROPHASE LABS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Free Cash Flow | Free Cash Flow to Debt | Total Liabilities |
---|---|---|---|
6/30/2025 | $ -10.97M | 0 | $ 30.61M |
3/31/2025 | $ -15.48M | 0 | $ 34.99M |
12/31/2024 | $ -18.21M | 0 | $ 55.85M |
9/30/2024 | $ -16.36M | 0 | $ 53.68M |
6/30/2024 | $ -17.55M | 0 | $ 49.6M |
3/31/2024 | $ -20.47M | 0 | $ 45.16M |
12/31/2023 | $ -14.46M | 0 | $ 42.54M |
9/30/2023 | $ -13.77M | 0 | $ 35.28M |
6/30/2023 | $ -6.29M | 0 | $ 31.8M |
3/31/2023 | $ 5.77M | 0.16 | $ 35.43M |
FCF / Liabilities
(=) FCF/D
FCF/D for PROPHASE LABS INC is calculated as follows: FCF [ $ 3.48M ] / Liabilities [ $ 12.27M ]
(=) FCF/D [ 0.28 ]
Minimum
Mar 31, 2023
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 2.25K |
---|---|
min | 0 |
max | 0.48 |
average | 0.11 |
median | 0.09 |
std | 0.11 |